Search - tctmd.com

August 12, 2025

News Daily News

DES Best for In-Stent Restenosis, but DCBs Also Viable

August 13, 2024

News Daily News

As US Rollout Begins for Coronary DCBs, Interventionalists Mull Practice Changes

Todd Neale

May 03, 2024

News Daily News

DCB in STEMI Match DES Through 5 Years: REVELATION

March 27, 2024

News Daily News

Agent Coronary DCB Gets FDA Approval for In-Stent Restenosis

March 01, 2024

News Daily News

TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable

January 09, 2024

News Daily News

Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis

February 24, 2023

News Daily News

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

June 01, 2022

News Daily News

Routine IVUS in Peripheral Interventions Supported by Small RCT

March 09, 2022

News Daily News

Cardiac Deaths and Adverse Events After PCI Have Declined With Time

October 05, 2021

News Daily News

DCB Match DES for Treating Coronary In-Stent Restenosis: European Registry

September 15, 2021

News Daily News

No Harm, No Help With Bioabsorbable-Polymer Stents: Registry

March 01, 2021

News Daily News

Features of Complex CAD Carry Progressive Risk in PCI, Registry Confirms

October 08, 2020

News Daily News

In CAD, No Long-term Safety Signal for Paclitaxel DCBs: Meta-analysis

March 09, 2020

News Daily News

Balloon-Free PCI for SVG Stenosis Offers Ongoing Advantages: DIVA

February 11, 2020

News Daily News

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

February 10, 2020

News Daily News

FDA Panel Talks Labeling, Urges Cooperation for Paclitaxel Mortality Signal in PAD

June 20, 2019

News Daily News

Residual Inflammatory Risk and PCI: Worthy Biomarker or Merely Something Else to Measure?

Yael L. Maxwell

May 15, 2019

News Daily News

A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex